Home

Kwality Pharmaceuticals Ltd EPS

Image

Kwality Pharmaceuticals Ltd

NSE: KWALITYPHARMA

EPS

₹ 47.28

Last updated on: Dec 05, 2025

Key Highlights

  • The Earning per Share of Kwality Pharmaceuticals Ltd is ₹ 47.28 as of 05 Dec 25 .
  • The earning per share of Kwality Pharmaceuticals Ltd changed from ₹ 5.1 to ₹ 13.6 over 10 quarters. This represents a CAGR of 48.04% .

Historical Earning per Share of Kwality Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Kwality Pharmaceuticals Ltd

Market Cap

929 Cr

EPS

47.3

P/E Ratio (TTM)

18.9

P/B Ratio (TTM)

3.2

Day’s High

909.0

Day’s Low

880.0

DTE

0.4

ROE

16.9

52 Week High

1235.0

52 Week Low

596.05

ROCE

18.8

Market Price of Kwality Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Kwality Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
05 Dec 2025895.7
04 Dec 2025888
03 Dec 2025905.65
02 Dec 2025921.75
01 Dec 2025923.4
28 Nov 2025931.45
27 Nov 2025922.65
26 Nov 2025908.2
25 Nov 2025897.6
24 Nov 2025898.15

SWOT Analysis Of Kwality Pharmaceuticals Ltd

Strength

1

che

Weakness

0

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Kwality Pharmaceuticals Ltd

Asset Value vs Market Value of Kwality Pharmaceuticals Ltd

Market Value

929

Asset Value

Value addition

2.3 X

285

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Kwality Pharmaceuticals Ltd929.4
Sun Pharmaceutical Industries Ltd433068
Divis Laboratories Ltd171847
Torrent Pharmaceuticals Ltd127979
Cipla Ltd122826
Dr Reddys Laboratories Ltd106418

Historical Market Cap of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Kwality Pharmaceuticals Ltd News Hub

Kwality Pharmaceuticals consolidated net profit rises 54.24% in the June 2024 quarter

Net profit of Kwality Pharmaceuticals rose 54.24% to Rs 8.36 crore in the quarter ended June 2024 as

Read more

12 Aug 24

Kwality Pharmaceuticals to discuss results

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 August 20

Read more

06 Aug 24

Kwality Pharmaceuticals schedules AGM

Kwality Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held

Read more

10 Sept 24

Kwality Pharmaceuticals to conduct AGM

Kwality Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held

Read more

10 Sept 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Kwality Pharmaceuticals Ltd

What is the EPS of Kwality Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Kwality Pharmaceuticals Ltd is 47.28. An EPS is the amount of net income attributed to each share of a common stock.

How is Kwality Pharmaceuticals Ltd EPS calculated?

The EPS of Kwality Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Kwality Pharmaceuticals Ltd report its EPS?

Kwality Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Kwality Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Kwality Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Kwality Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Kwality Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions